These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 15655708
1. Beta- and alpha-cell dysfunction in type 2 diabetes. Del Prato S, Marchetti P. Horm Metab Res; 2004; 36(11-12):775-81. PubMed ID: 15655708 [Abstract] [Full Text] [Related]
4. Banting lecture 1990. Beta-cells in type II diabetes mellitus. Porte D. Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568 [Abstract] [Full Text] [Related]
6. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J. N Engl J Med; 1992 Jan 02; 326(1):22-9. PubMed ID: 1727062 [Abstract] [Full Text] [Related]
7. Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver. Halter JB, Ward WK, Porte D, Best JD, Pfeifer MA. Am J Med; 1985 Aug 23; 79(2B):6-12. PubMed ID: 2863979 [Abstract] [Full Text] [Related]
8. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ. J Clin Endocrinol Metab; 2003 Jun 23; 88(6):2706-13. PubMed ID: 12788877 [Abstract] [Full Text] [Related]
9. Islet-cell abnormalities in non-insulin-dependent diabetes mellitus. Raskin P. Am J Med; 1985 Aug 23; 79(2B):2-5. PubMed ID: 3898829 [Abstract] [Full Text] [Related]
10. Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus. Walter H, Lübben G. Drugs; 2005 Aug 23; 65(1):1-13. PubMed ID: 15610048 [Abstract] [Full Text] [Related]
11. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Guillam MT, Hümmler E, Schaerer E, Yeh JI, Birnbaum MJ, Beermann F, Schmidt A, Dériaz N, Thorens B. Nat Genet; 1997 Nov 23; 17(3):327-30. PubMed ID: 9354799 [Abstract] [Full Text] [Related]
13. Phasic insulin release and metabolic regulation in type 2 diabetes. Del Prato S, Marchetti P, Bonadonna RC. Diabetes; 2002 Feb 23; 51 Suppl 1():S109-16. PubMed ID: 11815468 [Abstract] [Full Text] [Related]
14. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential. Østoft SH. Dan Med J; 2015 Sep 23; 62(9):. PubMed ID: 26324089 [Abstract] [Full Text] [Related]
15. Beta-cell function and mass in type 2 diabetes. Larsen MO. Dan Med Bull; 2009 Aug 23; 56(3):153-64. PubMed ID: 19728971 [Abstract] [Full Text] [Related]
16. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion. Abels M, Riva M, Bennet H, Ahlqvist E, Dyachok O, Nagaraj V, Shcherbina L, Fred RG, Poon W, Sörhede-Winzell M, Fadista J, Lindqvist A, Kask L, Sathanoori R, Dekker-Nitert M, Kuhar MJ, Ahrén B, Wollheim CB, Hansson O, Tengholm A, Fex M, Renström E, Groop L, Lyssenko V, Wierup N. Diabetologia; 2016 Sep 23; 59(9):1928-37. PubMed ID: 27338624 [Abstract] [Full Text] [Related]
17. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37). Hosokawa YA, Hosokawa H, Chen C, Leahy JL. J Clin Invest; 1996 Jan 01; 97(1):180-6. PubMed ID: 8550831 [Abstract] [Full Text] [Related]
19. Islet dysfunction in non-insulin-dependent diabetes mellitus. Kahn SE, Porte D. Am J Med; 1988 Nov 28; 85(5A):4-8. PubMed ID: 3057894 [Abstract] [Full Text] [Related]